Kayyem Jon Faiz bought INBX

September 8, 2026 · Form 4 insider transaction

Kayyem Jon Faiz bought 5,000 shares of Inhibrx Biosciences, Inc. at $113.52 per share, a transaction worth $567.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
5,000
Price
$113.52
Total value
$567.6K
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 8, 2026
Filing dateSeptember 8, 2026
Shares owned after424,360
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The shares were purchased in multiple transactions at prices ranging from $113.30 to $113.55 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.; These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.

View the original Form 4 on SEC EDGAR